RetinalGenix Technologies Inc RTGN
Trading Information
- Previous Close Price
- $3.20
- Day Range
- $4.00–4.00
- 52-Week Range
- $3.20–4.01
- Bid/Ask
- $1.50 / $4.00
- Shares Outstanding
- 18.84M
- Market Cap
- $75.02M
- Volume/Avg
- 800 / 754
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
RetinalGenix Technologies Inc is an ophthalmic research and development company focused on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders, Its mission is to prevent vision loss and blindness due to diabetic retinopathy and maculopathy through early detection from the use of two devices: Retinal Imaging Screening Device a portable, retinal imaging system providing a wide field of view without requiring pupil dilation; and RetinalCamTM, being designed as a high-resolution home monitoring retinal imaging device and physician alert system offering real-time communication with physicians available.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- —
- Total Number of Employees
- 0
- Website
- https://www.retinalgenix.com
Valuation
|
Metric
|
RTGN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
RTGN
|
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.01 |
Interest Coverage | −287.61 |
Quick Ratio
RTGN
Profitability
|
Metric
|
RTGN
|
|---|---|
Return on Assets (Normalized) | −8,707.41% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
RTGN
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|kjZ<t!@ | LOCK|KVT>B | $187B | |||
| Medtronic PLC
MDT
| LOCK|jQQNWR | LOCK|@#S^@ | $120B | |||
| Stryker Corp
SYK
| LOCK|>!F&qvdB | LOCK|&@M | $116B | |||
| Boston Scientific Corp
BSX
| LOCK|@FVx<& | LOCK|Qjp@^ | $69B | |||
| Edwards Lifesciences Corp
EW
| LOCK|^Kd&lW? | LOCK|><zzM | $52B | |||
| DexCom Inc
DXCM
| LOCK|h%%%wdN< | LOCK|pf&y | $33B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|hCxk?r | LOCK|T&Y | $31B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|!G | LOCK|Y#% | $25B | |||
| Steris PLC
STE
| LOCK|?<SCvH | LOCK|N#&# | $22B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|#DjMD<V& | LOCK|q@ | $19B |
United States